Cancer Research Technology
Log in Register
Menu

Raf KI D486A Mouse

Invented at University Of Leicester

Info

Catalogue Number 151475
Antigen/Gene or Protein Targets Raf1 D486A (oncogenic mutant)
Disease Keywords Cancer;
Relevance Knockin of oncogenic Raf-1D486A; in vivo study of oncogenic Raf-1 mutant, and Ras signalling
Production Details A Raf-1 targeting vector, encoding Raf-1 with a substitution at residue 486 (D to A) and a loxP flanked resistance cassette, was transfected into 129Ola ES cells. Raf-1 was targeted by homologous recombination with the targeting vector. Correctly targeted ES cells were transfected with a Cre expressing vector to excise the resistance cassette, before injection into C57BL/6 blastocysts. Chimeric offspring were bred with C57BL/6 mice to yield mice heterozygous for the mutant allele.
Conditional No
Mouse Genetic Background/Cross History C57BL/6
Research Area Cancer, Cell Signaling & Signal Transduction, Epigenetics & Nuclear Signalling, Genetic Studies Tools, Neurobiology

References

There are 4 reference entries for this reagent.

View All References

References: 4 entries

Kamata et al. 2010. Cancer Res. 70(21):8475-86. PMID: 20978199.

BRAF inactivation drives aneuploidy by deregulating CRAF.

Europe PMC ID: 20978199

Noble et al. 2008. Mol Cell. 31(6):862-72. PMID: 18922468.

CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.

Europe PMC ID: 18922468


Add a reference

References: 4 entries

Kamata et al. 2010. Cancer Res. 70(21):8475-86. PMID: 20978199.

BRAF inactivation drives aneuploidy by deregulating CRAF.

Noble et al. 2008. Mol Cell. 31(6):862-72. PMID: 18922468.

CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor